Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Equity Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Equity Ratio data on record, last reported at 0.01 in Q2 2025.

  • For Q2 2025, Equity Ratio fell 87.47% year-over-year to 0.01; the TTM value through May 2025 reached 0.01, down 87.47%, while the annual FY2025 figure was 0.01, 87.47% down from the prior year.
  • Equity Ratio reached 0.01 in Q2 2025 per LFCR's latest filing, down from 0.01 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.44 in Q1 2022 and bottomed at 0.06 in Q3 2023.
  • Average Equity Ratio over 5 years is 0.18, with a median of 0.11 recorded in 2023.
  • Peak YoY movement for Equity Ratio: crashed 118.88% in 2023, then skyrocketed 946.45% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.37 in 2021, then tumbled by 30.42% to 0.26 in 2022, then plummeted by 97.76% to 0.01 in 2023, then surged by 946.45% to 0.06 in 2024, then plummeted by 90.77% to 0.01 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.01 in Q2 2025, 0.01 in Q1 2025, and 0.06 in Q4 2024.